C0205108||Distal
C0205107||proximal
C0009368||colonic
C0574032||acetate infusions
C0184511||improve
C0578570||metabolic markers
C0497406||overweight
C0028754||obese
C0025266||men
C0015691||short-chain fatty acids
C0015691||short-chain fatty acids
C0025519||metabolism
C0035648||cardiometabolic risk factors
C0205107||proximal
C0205108||distal
C0009368||colonic
C0574032||infusions
C0015691||SCFA acetate
C0025266||men
C0034656||randomized
C0013072||double-blind
C0150097||crossover trial
C0497406||overweight
C0028754||obese
C0025266||men
C1305855||body mass index
C1305855||body mass index
C0205108||distal
C0205107||proximal
C0009368||colonic
C2034525||sodium acetate infusions
C2945625||feeding catheter
C0442418||endoscopically
C0733755||positioned
C0009368||colon
C0009368||colonic
C0574032||acetate
C1696465||placebo
C0574032||infusion
C0015663||fasting
C1955477||oral glucose load
C0014272||energy expenditure
C0025080||open-circuit ventilated hood system
C0178913||blood samples
C0015663||fasting
C0205108||Distal
C0009368||colonic
C0574032||acetate infusions
C0015663||fasting
C0015663||fasting
C0070358||peptide YY
C0070358||peptide YY
C0017725||glucose
C0021641||insulin
C0015663||fasting
C0032105||plasma
C0000975||acetate
C1696465||placebo
C0205108||Distal
C0574032||acetate administration
C0015663||fasting
C1456820||tumour necrosis factor-α
C1456820||tumour necrosis factor-α
C1696465||placebo
C0205107||proximal
C0009368||colonic
C0574032||acetate infusions
C0025519||metabolism
C0019932||hormones
C0005516||markers
C0205108||distal
C0009368||colonic
C0574032||acetate infusions
C0444584||whole-body
C0025519||metabolism
C0015663||fasting
C0032105||plasma
C0070358||peptide YY
C0443264||Modulating
C0009368||colonic
C0000975||acetate
C0087111||treat
C0025517||metabolic disorders